← ANALYST RATINGS · TIPRANKS

Alignment Healthcare (ALHC): analyst forecast and price target

$8.28 +1.60% close 16.10.26 · market cap $1.7B · Healthcare · Medical - Healthcare Plans IWM 0.06%
Price targets and ratings of

Analyst consensus

Moderate Buy

1 Buy2 Hold0 Sell

Ratings of 3 analysts in the last 3 months · top analysts only

12-month forecast

$17.00+105.3% upside

Based on 3 price targets given in the last 3 months, the average target is $17.00, the highest $25.00, the lowest $9.00. The average is +105.3% from the last price of $8.28.

$10.00$15.00$20.00$25.00Jan 26AprJulOctJan 27AprJulOctHigh$25.00Average$17.00Low$9.00
Highest target $25.00 Average target $17.00 Lowest target $9.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Jonathan Yong★★★★★★★★★★#3083 · hits 56% · avg +12.7% UBS $22.00 → $9.00−59.1% Hold +8.7% Assigned 12.10.26on TipRanks 08:15 +7.3%next day +2.6%
Gary Taylor★★★★★★★★★★#11148 · hits 44% · avg −4.0% TD Cowen $21.00 → $12.00−42.9% Buy +44.9% Reiterated 12.10.26on TipRanks 08:10 +7.3%next day +2.6%
Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% Bank of America Securities $25.00 → $9.00−64.0% Hold +8.7% Downgrade 09.10.26on TipRanks 08:45 −14.0%next day +7.3% · 5 days +11.7%
John Stansel★★★★★★★★★★#9374 · hits 46% · avg −2.3% J.P. Morgan $22.00 → $10.00−54.5% Buy +20.8% Reiterated 09.10.26on TipRanks 07:15 −14.0%next day +7.3% · 5 days +11.7%
Ryan Daniels★★★★★★★★★★#2878 · hits 48% · avg +5.8% William Blair — Hold — Downgrade 09.10.26on TipRanks 05:07 −14.0%next day +7.3% · 5 days +11.7%
Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% KeyBanc $28.00 → $12.00−57.1% Buy +44.9% Reiterated 09.10.26on TipRanks 04:30 −14.0%next day +7.3% · 5 days +11.7%
Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% Barclays $16.00 → $10.00−37.5% Hold +20.8% Reiterated 06.10.26on TipRanks 09:25 −2.1%next day +2.4% · 5 days −0.7%
Jessica Tassan★★★★★★★★★★#11189 · hits 43% · avg −3.3% Piper Sandler — Buy — Reiterated 05.10.26on TipRanks 08:50 +6.4%next day −2.1% · 5 days −5.2%
Parker Snure★★★★★★★★★★#8410 · hits 67% · avg +1.7% Raymond James $22.00 → $19.00−13.6% Buy +129.5% Reiterated 03.08.26on TipRanks 07:35 −3.4%next day −8.9% · 5 days −7.4%
Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% TD Cowen $25.00 → $21.00−16.0% Buy +153.6% Assigned 03.08.26on TipRanks Jul 31 17:30 −3.4%next day −8.9% · 5 days −7.4%
Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% Goldman Sachs $25.00 Buy +201.9% Reiterated 02.08.26on TipRanks Aug 3 08:55 −3.4%next day −8.9% · 5 days −7.4%
Michael Craig Jones★★★★★★★★★★#11984 · hits 45% · avg −19.2% Bank of America Securities — Buy — Reiterated 31.07.26on TipRanks 12:22 −20.9%next day −3.4% · 5 days −6.7%
Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% Robert W. Baird $22.00 → $28.00+27.3% Buy +238.2% Reiterated 30.01.26on TipRanks 07:31 +0.4%next day 0.0% · 5 days −3.3%

The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included

Best analysts covering Alignment Healthcare

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Michael Ha★★★★★★★★★★Robert W. Baird · #10152
Hits 42%25 of 60 Average return −2.4%
1 year Michael Ha★★★★★★★★★★Robert W. Baird · #10152
Hits 42%25 of 60 Average return −2.4%
2 years Michael Ha★★★★★★★★★★Robert W. Baird · #10152
Hits 42%25 of 60 Average return −2.4%

Most profitable

3 months Michael Ha★★★★★★★★★★Robert W. Baird · #10152
Hits 42%25 of 60 Average return −2.4%
1 year Michael Ha★★★★★★★★★★Robert W. Baird · #10152
Hits 42%25 of 60 Average return −2.4%
2 years Michael Ha★★★★★★★★★★Robert W. Baird · #10152
Hits 42%25 of 60 Average return −2.4%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $21.86 at a price of $8.16 (+167.9%); now: $13.25 at $8.28 (+60.0%).

$10.00$15.00$20.00$25.00Sep 15Oct 1Oct 15Top analysts$17.00Average target$13.25Price$8.28

PriceAverage targetTop analysts’ target

Recommendation trend · top analysts

0246831Oct 2542Nov52Dec42Jan 2641Feb21Mar2Apr31May31Jun62Jul141Aug151Sep112Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy000111
Buy336451
Hold112112
Sell000000

Earnings and sales forecast

Next report: 29.10.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $-0.04 (from $-0.06 to $-0.01). Last quarter: $0.17.

Sales

Next quarter’s sales estimate — $1.3B (from $1.3B to $1.3B). Last quarter: $1.3B.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Alignment Healthcare

Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.

Data from the stock’s TipRanks forecast page, read 17 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗